EUVIMEDEUVIMED entdecken
Open Access

A Simple and Sensitive LC–MS/MS Method for Simultaneous Quantification of Dasatinib and Erythromycin in Mice Plasma: Application to Preclinical Pharmacokinetic Study

Avinash Kumar, Nirbhay Kumar Tiwari, Sanjeev Giri, Ramesh Patnam, Rameshwar Ameta

Biomedical Chromatography · 2026-08 · 40 (8)

DOI: 10.1002/bmc.70533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 10.07.2026. Verfasst von Avinash Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pacific Academy of Higher Education and Research University (PAHER), Udaipur, Rajasthan, India. Hauptthemen laut MEDLINE: Erythromycin, Tandem Mass Spectrometry, Dasatinib, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dasatinib (DAS) is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML) and erythromycin (ERY) is macrolide antibiotic used to treat a range of inflammatory conditions are often co‐administered in clinical practice. The simultaneous estimation of DAS and ERY helps in understanding the pharmacokinetics and drug–drug interactions. In this respect, we presented novel, sensitive, and validated bio‐analytical LC‐ESI‐MS/MS method for simultaneous estimation of DAS and ERY in CD‐1 mice plasma. The LLOQ was 2.0 ng/mL with an S/N ratio of 15. This validated method was used to study the PK of DAS and ERY in mice following intravenous and oral administration. The DAS was administered at 5 mg/kg via both oral and intraveneous route, whereas ERY was administered at 50 mg/kg orally and 5 mg/kg intraveneousaly. Following intravenous dosing, DAS showed high clearance and distribution, while ERY exhibited high clearance and distribution. The oral bioavailability was 64% for DAS and 21% for ERY. When co‐administered orally at 5 mg/kg for DAS and 50 mg/kg of ERY, the AUC and C max of DAS were unchanged. However, the systemic exposure (w.r.t AUC and C max ) of ERY was slightly higher (2.4‐fold) in the presence of DAS, which may be attributed because of the CYP3A4 inhibition potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythromycinTandem Mass SpectrometryDasatinibLiquid Chromatography-Mass SpectrometryAnimalsMiceReproducibility of ResultsMaleLinear ModelsLimit of DetectionAdministration, OralSensitivity and SpecificityChromatography, Liquid

Stichwörter der Autor:innen

LC–MS/MSdasatiniberythromycinmethod validationmice plasmapharmacokinetics

Substanzen

ErythromycinDasatinib

Autor:innen und Institutionen

  • Department of Chemistry, Pacific Academy of Higher Education and Research University (PAHER), Udaipur, Rajasthan, India.
  • Drug Metabolism and Pharmacokinetic Department, Aurigene Oncology Limited, Bengaluru, Karnataka, India.
  • Prochem Organics Private Limited, Telangana, India.

Zitieren

APA

Kumar, A., Tiwari, N. K., Giri, S., Patnam, R., & Ameta, R. (2026). A Simple and Sensitive LC–MS/MS Method for Simultaneous Quantification of Dasatinib and Erythromycin in Mice Plasma: Application to Preclinical Pharmacokinetic Study. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70533

Vancouver

Kumar A, Tiwari NK, Giri S, Patnam R, Ameta R. A Simple and Sensitive LC–MS/MS Method for Simultaneous Quantification of Dasatinib and Erythromycin in Mice Plasma: Application to Preclinical Pharmacokinetic Study. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70533

BibTeX
@article{Kumar2026,
  author = {Kumar, Avinash and Tiwari, Nirbhay Kumar and Giri, Sanjeev and Patnam, Ramesh and Ameta, Rameshwar},
  title = {A Simple and Sensitive LC–MS/MS Method for Simultaneous Quantification of Dasatinib and Erythromycin in Mice Plasma: Application to Preclinical Pharmacokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/bmc.70533}
}
Kostenlos starten →